推荐产品
描述
n=45, m=28 (typical)
typical PEG PDI<1.1; overall PDI<1.4 (THF, PEO)
形狀
pellets
分子量
PDLLA average Mn 2,000
PEG average Mn 2,000
average Mn 4,000 (total)
降解時間
2-4 weeks
轉變溫度
Tg 11 °C (PEG block)
Tm 244-248 °C
Tg 88 °C (PDLLA block)
蛋白質二硫鍵異構酶
≤1.4
儲存溫度
2-8°C
一般說明
應用
特點和優勢
- 良好的生物相容性、低免疫原性和良好的降解性。
- 通过改变嵌段共聚物链段的尺寸可以轻松调节其性能,以适合特定应用。
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
商品
Local delivery of bioactive molecules using an implantable device can decrease the amount of drug dose required as well as non-target site toxicities compared to oral or systemic drug administration.
Microparticle drug delivery systems have been extensively researched and applied to a wide variety of pharmaceutical and medical applications due to a number of advantages including injectability, local applicability to target tissues and sites, and controlled drug delivery over a given time period.
Aliphatic polyesters such as polylactide, poly(lactide-co-glycolide) and polycaprolactone, as well as their copolymers, represent a diverse family of synthetic biodegradable polymers that have been widely explored for medical uses and are commercially available.
Aliphatic polyesters such as polylactide, poly(lactide-co-glycolide) and polycaprolactone, as well as their copolymers, represent a diverse family of synthetic biodegradable polymers that have been widely explored for medical uses and are commercially available.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门